Our response to the Telegraph

Gender Plus were approached by Michael Searles, Deputy Health Editor of the Telegraph, to comment on a piece they are running about Gender Plus Hormone Clinic following the NHS policy change on prescribing to trans 16 & 17 year olds. For transparency, and in the event that our statement is not replicated in full, we are also sharing it here.

Gender Plus - Telegraph statement - 11.03.26

The recent NHS England policy decision relates specifically to NHS-commissioned services. Independent providers operate under a different commissioning framework and must ensure that any care provided is clinically appropriate, evidence-informed, and delivered with robust safeguards, multidisciplinary assessment, and informed consent.

We recognise that this is an area of strong public interest and debate, and we take our responsibilities to young people and their families extremely seriously. Our priority is always the welfare, safety, and wellbeing of all those under our care. Treatment decisions are made on an individual basis following comprehensive assessment by experienced clinicians and with the involvement of patients and their families.

Our prescribing adheres to expert international guidelines such as the Endocrine Society’s Clinical Practice Guidelines, in addition to others.